A study of the efficacy and safety of albendazole (Zentel) in the treatment of intestinal helmenthiasis in Kenyan children less than 2 years of age.
One hundred children comprising of 57 males and 43 females aged between 8 and 24 months entered the study. 46 children had single and 54 children had multiple helminth infections. All children received albendazole 200 mg (10 ml) suspension as a single dose. Albendazole proved very effective and safe in the treatment of single and multiple helminth infections in children under 2 years of age, achieving cure rates of 100% in both Ascaris lumbricoides and Necator americanus respectively, 83% in Trichuris trichiura and 66% in Hymenolepis nana. Treatment of polyparasitism appears to be of benefit in improving nutritional status using haemoglobin concentrations as an index.
Pamba
H O
HO
Bwibo
N O
NO
Chunge
C N
CN
Estambale
B B
BB
D015766:Albendazole / Q000627:therapeutic use*; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male
D015766:Albendazole